Skip to main content

Drug-Induced Parkinsonism

  • Chapter
  • First Online:
Book cover Movement Disorders: A Video Atlas

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Drug-induced parkinsonism (DIP) is a common adverse effect of treatment with antipsychotic/neuroleptic drugs which block dopamine receptors in the striatum. These drugs include the phenothiazines, thioxanthenes, butyrophenones, and the newer-generation “atypical” antipsychotic drugs such as risperidone, olanzapine, ziprasidone, and aripiprazole. Antiemetics which block dopamine receptors such as prochlorperazine and metoclopramide and certain calcium channel blockers such as flunarizine are also common causes of DIP. DIP may be indistinguishable from Parkinson’s disease (PD) and includes various combinations of bradykinesia, rigidity, resting and action tremor. The incidence of DIP increases with age. In fact, asymmetric motor findings are not uncommon and in older individuals may represent an unmasking of subclinical PD.

This chapter contains a video segment which can be found at the URL: https://doi.org/10.1007/978-1-60327-426-5_20

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tarsy D. Movement disorders with neuroleptic drug treatment. Psych Clin North Am. 1984; 7:453–71.

    Article  CAS  Google Scholar 

  2. Chabolla DR, Maraganore DM, Ahlskog JE, et al. Drug-induced parkinsonism as a risk factor for Parkinson’s disease: a historical cohort study in Olmsted county, Minnesota. Mayo Clin Proc. 1998;73:724–7.

    Article  CAS  Google Scholar 

  3. Burn DJ, Brooks DJ. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study. Neurology. 1993;43:552–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Electronic Supplementary material

20 Drug-induced parkinsonism.mp4 (MP4 19,337KB)

Patient is in hospital displaying facial masking, reduced blink frequency, global bradykinesia, slow and hypokinetic, right finger and toe tapping, and slow gait with flexed posture, absent arm swing and en bloc turns following 10 days of treatment with haloperidol for hemiballismus (see Chap. 75).

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bhidayasiri, R., Tarsy, D. (2012). Drug-Induced Parkinsonism. In: Movement Disorders: A Video Atlas. Current Clinical Neurology. Humana, Totowa, NJ. https://doi.org/10.1007/978-1-60327-426-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-426-5_20

  • Published:

  • Publisher Name: Humana, Totowa, NJ

  • Print ISBN: 978-1-60327-425-8

  • Online ISBN: 978-1-60327-426-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics